Skip to main content

. 1980;10(Suppl 1):83S–84S. doi: 10.1111/j.1365-2125.1980.tb04911.x

Experiences with guanfacine in a two-year follow-up study

PMCID: PMC1430133 PMID: 6994785

83S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Esch I. Erste Erfahrungen mit BS 100-141, einer neuen blutdrucksenkenden Substanz. Int J Clin Pharmacol Biopharm. 1976 Sep;14(2):109–112. [PubMed] [Google Scholar]
MacCarthy P., Isaac P., Frost G., Freeman A., Stokes G. Clinical dose-response studies with guanfacine (BS 100-141), a new antihypertensive agent. Clin Exp Pharmacol Physiol. 1978 Mar-Apr;5(2):187–190. doi: 10.1111/j.1440-1681.1978.tb00669.x. [DOI] [PubMed] [Google Scholar]
Saameli K., Scholtysik G., Waite R. Pharmacology of BS 100-141, a centrally acting antihypertensive drug. Clin Exp Pharmacol Physiol. 1975;Suppl 2:207–212. [PubMed] [Google Scholar]

ACTIONS

RESOURCES